[go: up one dir, main page]

AU4332399A - Rna polymerase chain reaction - Google Patents

Rna polymerase chain reaction

Info

Publication number
AU4332399A
AU4332399A AU43323/99A AU4332399A AU4332399A AU 4332399 A AU4332399 A AU 4332399A AU 43323/99 A AU43323/99 A AU 43323/99A AU 4332399 A AU4332399 A AU 4332399A AU 4332399 A AU4332399 A AU 4332399A
Authority
AU
Australia
Prior art keywords
chain reaction
polymerase chain
rna polymerase
rna
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43323/99A
Inventor
Cheng-Ming Chuong
Shi-Lung Lin
Randall Bruce Widelitz
Shao-Yao Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENG MING CHUONG
SHI LUNG LIN
Original Assignee
CHENG MING CHUONG
SHI LUNG LIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENG MING CHUONG, SHI LUNG LIN filed Critical CHENG MING CHUONG
Publication of AU4332399A publication Critical patent/AU4332399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU43323/99A 1999-06-04 1999-06-04 Rna polymerase chain reaction Abandoned AU4332399A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/012461 WO2000075356A1 (en) 1999-06-04 1999-06-04 Rna polymerase chain reaction

Publications (1)

Publication Number Publication Date
AU4332399A true AU4332399A (en) 2000-12-28

Family

ID=22272895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43323/99A Abandoned AU4332399A (en) 1999-06-04 1999-06-04 Rna polymerase chain reaction

Country Status (2)

Country Link
AU (1) AU4332399A (en)
WO (1) WO2000075356A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064835A2 (en) * 2001-01-31 2002-08-22 Ambion, Inc. Methods for nucleic acid fingerprint analysis
JP2002262882A (en) * 2001-03-12 2002-09-17 Nisshinbo Ind Inc RNA amplification method
CA2450217A1 (en) * 2001-05-14 2002-11-21 Henry Hongjun Ji Novel method for cloning variable domain sequences of immunological gene repertoire
US8137911B2 (en) 2001-05-22 2012-03-20 Cellscript, Inc. Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
WO2004059289A2 (en) 2001-05-22 2004-07-15 Epicentre Technologies Target-dependent transcription using deletion mutants of n4 rna polymerase
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
EP1275738A1 (en) * 2001-07-11 2003-01-15 Roche Diagnostics GmbH Method for random cDNA synthesis and amplification
DE10143106C1 (en) * 2001-09-03 2002-10-10 Artus Ges Fuer Molekularbiolog Amplifying RNA, useful e.g. for analysis on a microarray, comprises conversion to double-stranded cDNA, strand separation and transcription
US7354742B2 (en) 2002-02-22 2008-04-08 Ortho-Mcneil Pharmaceutical, Inc. Method for generating amplified RNA
EP1371726A1 (en) * 2002-06-14 2003-12-17 Rijksuniversiteit Groningen Method for amplifying RNA
EP1585824A4 (en) 2002-11-21 2008-01-02 Epict Technologies Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
EP2471921A1 (en) 2004-05-28 2012-07-04 Asuragen, Inc. Methods and compositions involving microRNA
ES2534301T3 (en) 2004-11-12 2015-04-21 Asuragen, Inc. Procedures and compositions involving miRNA and miRNA inhibitor molecules
AU2007238624B2 (en) 2006-04-14 2012-05-31 Cellscript, Llc Kits and methods for generating 5' capped RNA
WO2008141514A1 (en) * 2007-05-17 2008-11-27 Wondergen Bio-Medicine Technology Co., Ltd. System substitute pcr
EP2173872B1 (en) 2007-06-29 2014-04-02 CellScript, Inc. Copy dna and sense rna
WO2009036332A1 (en) 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
EP2285960B1 (en) 2008-05-08 2015-07-08 Asuragen, INC. Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis
EP3578205A1 (en) 2010-08-06 2019-12-11 ModernaTX, Inc. A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
FI4108671T3 (en) 2010-10-01 2024-12-27 Modernatx Inc Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
US8710200B2 (en) 2011-03-31 2014-04-29 Moderna Therapeutics, Inc. Engineered nucleic acids encoding a modified erythropoietin and their expression
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
AU2012318752B2 (en) 2011-10-03 2017-08-31 Modernatx, Inc. Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
MX2014007233A (en) 2011-12-16 2015-02-04 Moderna Therapeutics Inc Modified nucleoside, nucleotide, and nucleic acid compositions.
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US10501512B2 (en) 2012-04-02 2019-12-10 Modernatx, Inc. Modified polynucleotides
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP3520821A1 (en) 2012-04-02 2019-08-07 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
WO2014081507A1 (en) 2012-11-26 2014-05-30 Moderna Therapeutics, Inc. Terminally modified rna
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
CA2926218A1 (en) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
CN112337414A (en) 2019-08-09 2021-02-09 胡桃钳医疗公司 Microfluidic device and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018176A1 (en) * 1992-03-11 1993-09-16 Dana-Farber Cancer Institute METHODS TO CLONE mRNA
EP0590327B1 (en) * 1992-09-11 2003-04-09 F. Hoffmann-La Roche Ag Detection of nucleic acids in blood

Also Published As

Publication number Publication date
WO2000075356A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
AU4332399A (en) Rna polymerase chain reaction
AU4518601A (en) Microarray hybridization chamber
AU2001268513A1 (en) Nucleic acid accessible hybridization sites
AU3243099A (en) Multi-zone polymerase/ligase chain reaction
AU3369900A (en) Gene silencing
AU3678100A (en) Biosensor
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2003272203A1 (en) Multiplex nucleic acid reactions
AUPS076902A0 (en) Novel selective polymerase chain reaction
AU2001272482A1 (en) Osteolevin gene polymorphisms
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
AU2002327236A1 (en) Multiplex nucleic acid reactions
AU2877000A (en) Photo-induced nucleic acid hybridization
AU2003269908A1 (en) Multiplex nucleic acid reactions
DE69833112D1 (en) Rna polymerase
AU2002245107A1 (en) Improved biochip
AU6488800A (en) Dna sequences specific to rice centromeres
AU1812801A (en) Short shared nucleotide sequences
AU2000269393A1 (en) Integrated nucleic acid hybridization devices
AU7461900A (en) Nucleotide sequences
AU1870000A (en) Gene therapy-2
AU6871900A (en) Tsg-like gene
GB9905644D0 (en) Dna
AU4543000A (en) Reaction block

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase